[Clopidogrel and aspirin versus aspirin alone in prevention of atherothrombotic events. The results of CHARISMA study].
Gaciong
Zbigniew
Z
Katedra i Klinika Chorób Wewnetrznych, Nadciśnienia Tetniczego i Angiologii, ul. Banacha 1a, 02-097 Warszawa. zgaciong@hotmail.com
D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy / Q000517:prevention & control*; D001241:Aspirin / Q000008:administration & dosage*; D000077144:Clopidogrel; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D013927:Thrombosis / Q000188:drug therapy / Q000517:prevention & control*; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin